These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 37547254)
1. Short hydrocarbon stapled ApoC2-mimetic peptides activate lipoprotein lipase and lower plasma triglycerides in mice. Sviridov D; Dasseux A; Reimund M; Pryor M; Drake SK; Jarin Z; Wolska A; Pastor RW; Remaley AT Front Cardiovasc Med; 2023; 10():1223920. PubMed ID: 37547254 [TBL] [Abstract][Full Text] [Related]
2. A dual apolipoprotein C-II mimetic-apolipoprotein C-III antagonist peptide lowers plasma triglycerides. Wolska A; Lo L; Sviridov DO; Pourmousa M; Pryor M; Ghosh SS; Kakkar R; Davidson M; Wilson S; Pastor RW; Goldberg IJ; Basu D; Drake SK; Cougnoux A; Wu MJ; Neher SB; Freeman LA; Tang J; Amar M; Devalaraja M; Remaley AT Sci Transl Med; 2020 Jan; 12(528):. PubMed ID: 31996466 [TBL] [Abstract][Full Text] [Related]
3. A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice. Amar MJ; Sakurai T; Sakurai-Ikuta A; Sviridov D; Freeman L; Ahsan L; Remaley AT J Pharmacol Exp Ther; 2015 Feb; 352(2):227-35. PubMed ID: 25395590 [TBL] [Abstract][Full Text] [Related]
4. Creation of Apolipoprotein C-II (ApoC-II) Mutant Mice and Correction of Their Hypertriglyceridemia with an ApoC-II Mimetic Peptide. Sakurai T; Sakurai A; Vaisman BL; Amar MJ; Liu C; Gordon SM; Drake SK; Pryor M; Sampson ML; Yang L; Freeman LA; Remaley AT J Pharmacol Exp Ther; 2016 Feb; 356(2):341-53. PubMed ID: 26574515 [TBL] [Abstract][Full Text] [Related]
5. Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia. Liu C; Gates KP; Fang L; Amar MJ; Schneider DA; Geng H; Huang W; Kim J; Pattison J; Zhang J; Witztum JL; Remaley AT; Dong PD; Miller YI Dis Model Mech; 2015 Aug; 8(8):989-98. PubMed ID: 26044956 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein C-II mimetic peptide is an efficient activator of lipoprotein lipase in human plasma as studied by a calorimetric approach. Reimund M; Wolska A; Risti R; Wilson S; Sviridov D; Remaley AT; Lookene A Biochem Biophys Res Commun; 2019 Oct; 519(1):67-72. PubMed ID: 31477272 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein lipase regulates hematopoietic stem progenitor cell maintenance through DHA supply. Liu C; Han T; Stachura DL; Wang H; Vaisman BL; Kim J; Klemke RL; Remaley AT; Rana TM; Traver D; Miller YI Nat Commun; 2018 Apr; 9(1):1310. PubMed ID: 29615667 [TBL] [Abstract][Full Text] [Related]
8. Incorporation of Putative Helix-Breaking Amino Acids in the Design of Novel Stapled Peptides: Exploring Biophysical and Cellular Permeability Properties. Partridge AW; Kaan HYK; Juang YC; Sadruddin A; Lim S; Brown CJ; Ng S; Thean D; Ferrer F; Johannes C; Yuen TY; Kannan S; Aronica P; Tan YS; Pradhan MR; Verma CS; Hochman J; Chen S; Wan H; Ha S; Sherborne B; Lane DP; Sawyer TK Molecules; 2019 Jun; 24(12):. PubMed ID: 31226791 [TBL] [Abstract][Full Text] [Related]
9. Inverse effects of APOC2 and ANGPTL4 on the conformational dynamics of lid-anchoring structures in lipoprotein lipase. Kumari A; Grønnemose AL; Kristensen KK; Winther AL; Young SG; Jørgensen TJD; Ploug M Proc Natl Acad Sci U S A; 2023 May; 120(18):e2221888120. PubMed ID: 37094117 [TBL] [Abstract][Full Text] [Related]
10. Regulation of lipoprotein lipase-mediated lipolysis of triglycerides. Basu D; Goldberg IJ Curr Opin Lipidol; 2020 Jun; 31(3):154-160. PubMed ID: 32332431 [TBL] [Abstract][Full Text] [Related]
11. ApoC2 deficiency elicits severe hypertriglyceridemia and spontaneous atherosclerosis: A rodent model rescued from neonatal death. Gao M; Yang C; Wang X; Guo M; Yang L; Gao S; Zhang X; Ruan G; Li X; Tian W; Lu G; Dong X; Ma S; Li W; Wang Y; Zhu H; He J; Yang H; Liu G; Xian X Metabolism; 2020 Aug; 109():154296. PubMed ID: 32562799 [TBL] [Abstract][Full Text] [Related]
12. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia. Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148 [TBL] [Abstract][Full Text] [Related]
14. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects. Di Filippo M; Marçais C; Charrière S; Marmontel O; Broyer M; Delay M; Merlin M; Nollace A; Valéro R; Lagarde M; Pruneta-Deloche V; Moulin P; Sassolas A PLoS One; 2014; 9(6):e99721. PubMed ID: 24886863 [TBL] [Abstract][Full Text] [Related]
15. Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer. Liu G; Excoffon KJ; Wilson JE; McManus BM; Miao L; Benoit P; Duverger N; Branellec D; Denefle P; Hayden MR; Lewis ME Clin Invest Med; 1998; 21(4-5):172-85. PubMed ID: 9800066 [TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein C-II: the re-emergence of a forgotten factor. Wolska A; Reimund M; Remaley AT Curr Opin Lipidol; 2020 Jun; 31(3):147-153. PubMed ID: 32332429 [TBL] [Abstract][Full Text] [Related]
17. A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis. Jiang J; Wang Y; Ling Y; Kayoumu A; Liu G; Gao X Lipids Health Dis; 2016 Jan; 15():12. PubMed ID: 26772541 [TBL] [Abstract][Full Text] [Related]
18. Correction of feline lipoprotein lipase deficiency with adeno-associated virus serotype 1-mediated gene transfer of the lipoprotein lipase S447X beneficial mutation. Ross CJ; Twisk J; Bakker AC; Miao F; Verbart D; Rip J; Godbey T; Dijkhuizen P; Hermens WT; Kastelein JJ; Kuivenhoven JA; Meulenberg JM; Hayden MR Hum Gene Ther; 2006 May; 17(5):487-99. PubMed ID: 16716106 [TBL] [Abstract][Full Text] [Related]